Abstract
The FAMMM syndrome consists of the familial occurrence of cutaneous malignant melanoma and atypical nevi (dysplastic nevi), and is inherited as an autosomal dominant trait. Conflicting results have been reported on the question of whether the syndrome includes increased susceptibility to non-melanoma cancers. We have studied cancer of all anatomic sites and histologies in nine FAMMM families which were ascertained in a pigmented lesions clinic in the Netherlands. We evaluated two hypotheses: that the number of systemic cancers observed in the families was excessive, compared to expected incidence, based on Dutch incidence data, and that there was variation (or heterogeneity) among families in the frequency of systemic cancer. A significant excess of systemic cancer (especially digestive tract cancer) was observed. Significant heterogeneity was also found among the families; three of the nine families had marked excess in numbers of systemic cancers, and the remaining families had normal numbers of cancers among the known FAMMM gene carriers and their first degree relatives. Thus, we provide evidence of increased susceptibility to systemic cancer occurring in conjunction with the FAMMM syndrome in a subset of this resource.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bergman W., Palan A., Went L. N. Clinical and genetic studies in six Dutch kindreds with the dysplastic naevus syndrome. Ann Hum Genet. 1986 Jul;50(Pt 3):249–258. doi: 10.1111/j.1469-1809.1986.tb01046.x. [DOI] [PubMed] [Google Scholar]
- Bergman W., Ruiter D. J., Scheffer E., van Vloten W. A. Melanocytic atypia in dysplastic nevi. Immunohistochemical and cytophotometrical analysis. Cancer. 1988 Apr 15;61(8):1660–1666. doi: 10.1002/1097-0142(19880415)61:8<1660::aid-cncr2820610825>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
- Breslow N. E., Day N. E. Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. IARC Sci Publ. 1987;(82):1–406. [PubMed] [Google Scholar]
- Greene M. H., Tucker M. A., Clark W. H., Jr, Kraemer K. H., Elder D. E., Fraser M. C. Hereditary melanoma and the dysplastic nevus syndrome: the risk of cancers other than melanoma. J Am Acad Dermatol. 1987 Apr;16(4):792–797. doi: 10.1016/s0190-9622(87)70103-0. [DOI] [PubMed] [Google Scholar]
- Jagelman D. G. Extracolonic manifestations of familial polyposis coli. Cancer Genet Cytogenet. 1987 Aug;27(2):319–325. doi: 10.1016/0165-4608(87)90014-8. [DOI] [PubMed] [Google Scholar]
- Kraemer K. Dysplastic nevi as precursors to hereditary melanoma. J Dermatol Surg Oncol. 1983 Aug;9(8):619–622. doi: 10.1111/j.1524-4725.1983.tb00869.x. [DOI] [PubMed] [Google Scholar]
- Lynch H. T., Fain P. R., Golgar D., Albano W. A., Mailliard J. A., McKenna P. Familial breast cancer and its recognition in an oncology clinic. Cancer. 1981 Jun 1;47(11):2730–2739. doi: 10.1002/1097-0142(19810601)47:11<2730::aid-cncr2820471132>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
- Lynch H. T., Fusaro R. M., Kimberling W. J., Lynch J. F., Danes B. S. Familial atypical multiple mole-melanoma (FAMMM) syndrome: segregation analysis. J Med Genet. 1983 Oct;20(5):342–344. doi: 10.1136/jmg.20.5.342. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lynch H. T., Fusaro R. M., Pester J., Oosterhuis J. A., Went L. N., Rumke P., Neering H., Lynch J. F. Tumour spectrum in the FAMMM syndrome. Br J Cancer. 1981 Oct;44(4):553–560. doi: 10.1038/bjc.1981.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vasen H. F., Bergman W., van Haeringen A., Scheffer E., van Slooten E. A. The familial dysplastic nevus syndrome. Natural history and the impact of screening on prognosis. A study of nine families in the Netherlands. Eur J Cancer Clin Oncol. 1989 Feb;25(2):337–341. doi: 10.1016/0277-5379(89)90027-8. [DOI] [PubMed] [Google Scholar]